Results 71 to 80 of about 17,469 (165)
Leishmaniasis affects over 1 billion people worldwide, with current treatments limited by toxicity and efficacy. This study used machine learning (ML), QSAR, and polypharmacology to identify potential drug candidates, analyzing 12,072 compounds with random forest and XGBoost models.
Laís Salvador do Amaral+7 more
wiley +1 more source
Human visceral leishmaniasis is a growing anthropozoonosis in Brazil, and particularly in the southern region of the country. It is an infectious disease transmitted to humans, dogs and other animals in urban and rural areas of the Americas, mainly due ...
Ibrahim Clós Mahmud+4 more
doaj
La leishmaniasis visceral canina (LVC), producida por Leishmania infantum (=Leishmania chagasi) es una patología infecciosa zoonótica de importancia para la salud pública en países del Nuevo y Viejo Mundo. En Colombia se la encuentra distribuida en varios focos donde predomina el bosque seco tropical (Corredor et al., 1989).
openaire +4 more sources
Drug Resistance in Visceral Leishmaniasis [PDF]
Visceral leishmaniasis remains a public health problem worldwide. This illness was included by the World Health Organization in the list of neglected tropical diseases targeted for elimination by 2015. The widespread emergence of resistance to pentavalent antimonials in India where half cases occur globally and the unavailability of a vaccine in ...
openaire +3 more sources
Leishmaniasis in rheumatoid arthritis
Leishmaniasis represents a complex of diseases with an important clinical and epidemiological diversity. Visceral leishmaniasis is of higher priority than cutaneous leishmaniasis as it is a fatal disease in the absence of treatment. The clinical spectrum
M. Cutolo, M.E. Secchi, C. Pizzorni
doaj +1 more source
Pediatric visceral leishmaniasis in Albania
Visceral leishmaniasis (VL) in children is endemic in southern Europe but has not been previously reported from Albania. This prospective study reports the clinical and laboratory findings in 50 children with visceral leishmaniasis, the value of a direct agglutination test (DAT), and the result of treatment with meglumine antimonate.Sera obtained from ...
G. Sulcebe+4 more
openaire +3 more sources
Leishmaniasis in the Argentine Republic: Temporal and geographical distribution from 2013 to 2017
Objective: To assess the temporal and geographical distribution of confirmed cases of cutaneous, mucocutaneous and visceral leishmaniasis in the Argentine Republic from 2013 to 2017.
María J Germano+5 more
doaj +1 more source
[Spatial-temporal distribution of visceral leishmaniasis in Brazil from 2007 to 2020Distribución espaciotemporal de la leishmaniasis visceral en Brasil en el período 2007-2020]. [PDF]
Nina LNDS+5 more
europepmc +1 more source
Brhane Tesfanchal,1 Gebremedhin Gebremichail,2 Getachew Belay,1 Gebreslassie Gebremariam,3 Gebreyohannes Teklehaimanot,4 Hagos Haileslasie,2 Getachew Kahsu,1 Aderajew Gebrewahd,5 Fitsum Mardu,6 Gebre Adhanom,5 Brhane Berhe,6 Hirut Teame,7 Aster Tsegaye,8
Tesfanchal B+13 more
doaj
Interstitial pneumonitis in canine visceral leishmaniasis
Forty-one naturally infected dogs with visceral leishmaniasis from an urban area of Corumbá (Mato Grosso do Sul-BRAZIL) were studied and three types of lung involvement due to visceral leishmaniasis were characterized; a cellular, a cellular-fibrotic and
M. I. S. Duarte+5 more
doaj +1 more source